Big Pharma’s big tariffs
Swamp Notes
00:00
Intro
This chapter discusses a proposed 200 percent tariff on imported pharmaceuticals in the U.S. and its potential implications for the industry, including the possibility of reshoring manufacturing and the market's reaction to the announcement.
Transcript
Play full episode
